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1. Introduction
  Obesity has become one of the most common metabolic disorders 
and is a serious health problem, since it is a risk factor for metabolic 
syndromes such as type 2 diabetes, hyperlipidemia, hypertension, 
and arteriosclerosis[1-3]. Therefore, prevention and treatment of 
obesity are important for achieving a healthy lifestyle. Obesity is 
characterized by increased fat accumulation in adipose tissue[3], 
which results from an imbalance between energy intake and 
expenditure. This imbalance leads to an increase in adipocyte 
number and size; adipogenesis, including structural changes; an 
increase in adipogenic/lipogenic gene expression; and accumulation 
of lipids stored as excess energy in the form of triglycerides (TG)
[4-7]. Therefore, regulation of adipogenesis and TG accumulation 
is a potential therapeutic strategy to prevent and treat obesity and 
obesity-related diseases. 
  Monascus spp. have been consumed as the traditional edible fungi 
in Eastern Asia, including China and Korea. Monascus spp. are 
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known to produce several bioactive metabolites such as monacolins, 
and their metabolites and fermented products have been reported 
to be beneficial for obesity, regulation of lipid metabolism, and 
Alzheimer’s disease in many previous in vitro and in vivo studies[8-
12]. Black soybean (Glycine max L. Merrill) is a type of soybean with 
a black seed coat, which has been used as a traditional medicinal 
herb and health food for the prevention of several diseases and 
conditions such as diabetes and obesity[13-16]. In addition, black 
soybean has been fermented with filamentous fungi, including 
Aspergillus awamori, Aspergillus oryzae (A. oryzae), and Monascus 
pilosus (M. pilosus), and products of black soybean fermented with 
fungi have several useful biological effects, including antioxidant 
effects and reduced risk of atherosclerosis[17-19]. However, the 
effects of M. pilosus-fermented black soybean (MFBS) on obesity 
and the mechanisms involved in its anti-obesity effects are unknown. 
In this study, we examined the effects of MFBS extracts (MFBSE) 
and MFBS powders (MFBSP) on obesity and the underlying 
mechanisms in 3T3-L1 adipocytes and in high-fat diet (HFD)-
induced obese mice. 
2. Materials and methods
2.1. MFBSP and MFBSE preparation
  Black soybean (Glycine max L. Merrill) purchased from National 
Agriculture Cooperative Federation (Gyeonggi-Do, Republic of 
Korea) was washed with water and was homogenized to a small 
particle size. The homogenates were mixed with 10% wheat bran of 
homogenate weight/solid media weight; the mixture was autoclaved 
at 121 曟 for 90 min and then cooled under aseptic conditions at 
room temperature. Fermentation was performed following the 
method described by Lee et al[18]. The freeze-dried fermented 
sample (moisture content: <5%) was homogenized and was passed 
through 100 mesh sieve; the resulting material was used as a 
MFBSP. MFBSP (dry weight, 2 g) was extracted with 95% ethanol 
(20 mL) for 24 h and filtered. After filtration, the ethanol extracts 
were evaporated and dissolved in dimethyl sulfoxide (DMSO). The 
resulting material was used as MFBSE in experiments, and the final 
concentration of DMSO in the culture medium was adjusted to 
<0.1%.
2.2. 3T3-L1 adipocyte cell culture
  Mouse 3T3-L1 pre-adipocytes obtained from Dr. Sang-Dal Rhee 
(Korea Research Institute of Chemical Technology (Daejeon, Korea) 
were cultured in Dulbecco’s modified Eagle’s medium (DMEM) 
(New York, NY, USA) supplemented with 10% fetal bovine 
serum (FBS) and antibiotics (100 U/mL penicillin and 10 mg/mL 
streptomycin (Gibco BRL, Grand Island, NY, USA) at 37 曟 under 
a humidified 5% CO2 atmosphere. For differentiation of 3T3-L1 
pre-adipocytes to mature adipocytes, postconfluent cells (defined as 
day 0) were cultured in differentiation medium containing 0.5 mM 
3-isobutylmethylxanthine (Wako Pure Chemical Industries Ltd., 
Osaka, Japan), 5 毺g/mL insulin (Sigma-Aldrich, St Louis, MO, 
USA), and 1 毺M dexamethasone (Wako Pure Chemical Industries 
Ltd., Osaka, Japan) in DMEM supplemented with 10% FBS. After 
3 d, the cell culture medium was changed to DMEM containing
5 毺g/mL insulin and 10% FBS. Thereafter, the medium was 
replaced again with DMEM containing 10% FBS after 2 d for 4 d. 
To examine the effect of MFBSE on adipogenesis, the cells were 
treated with or without MFSBE during the adipogenic process. 
2.3. Oil-Red O staining
  After differentiation, cells were fixed with 4% formaldehyde 
solution in phosphate-buffered saline (PBS) for 1 h and then were 
washed three times with distilled water. The cells were stained with 
Oil-Red O (0.5% in 60% isopropanol) for 1 h and were washed 
three times with distilled water. Stained cells were photographed 
under an optical microscope. Stained lipid droplets were extracted 
with isopropanol, and the absorbance of the extracted lipids was 
measured at 520 nm using a microplate reader (Tecan, Mannedorf, 
Switzerland).
2.4. Cell viability assay
  Cells were treated with various concentrations (0, 25, 50, and 
100 毺M) of MFBSE in the DMEM containing 10% FBS for 48 
h. Filtered MTT reagent (5 mg/mL) was added to cells at a final 
concentration of 0.5 mg MTT/mL, and cells were incubated further 
for 4 h at 37 曟. Violet formazan crystals were dissolved in DMSO, 
and the absorbance was measured at 570 nm using a microplate 
reader. Cell viability (%) was calculated by comparing the 
absorbance of the treated samples with the absorbance of the control 
(untreated samples).
2.5. Animal experiments
  Five-week-old male C57BL/6J mice were purchased from Orient 
Bio (Sung-Nam, South Korea). The mice were housed under 
temperature-[(23依3) 曟] and humidity-controlled conditions with a 
12-h light/dark cycle and were given free access to water and food 
throughout the experiment. After acclimatization with a standard 
rodent normal-fat diet (NFD) (CRF-1, Charles River, Japan) for 
1 week, the mice were fed either the NFD (NFD control) or HFD 
(60% Kcal Fat, Cat #101556; Research Diets, NJ, USA) for 4 
weeks to induce obesity. Based on their body weights, HFD-fed 
mice were divided into two experimental groups (n=5/group) and 
treated without (HFD control) or with 1 g/kg M. pilosus-fermented 
black soybean powder (MFBSP). MFBSP was mixed with distilled 
water and administered by oral gavage once daily for 12 weeks 
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while continuing the HFD. The control NFD and HFD groups 
were administered distilled water alone. Body weight and food 
intake were measured twice per week throughout the study. The 
experimental design was approved by the Ethics Committee of the 
Wonkwang University (Iksan, Jeonbuk, Republic of Korea), and the 
mice were maintained in accordance with their guidelines.
2.6. Collection of liver and white adipose tissue (WAT)
  At the end of the 12-week treatment period, the mice were 
sacrificed, and the liver and WAT were excised immediately, 
rinsed, weighed, frozen in liquid nitrogen, and stored at -80 曟 until 
analysis. 
2.7. Total RNA isolation and gene expression analysis
  Total RNA was isolated from 3T3-L1 adipocytes using the SV Total 
RNA Isolation System (Promega, Madison, WI, USA) according 
to the manufacturer’s protocol. Total RNA (1 毺g) was reverse-
transcribed to cDNA by using a reverse transcription system (a3500; 
Promega, Madison, WI, USA) according to the manufacturer’s 
protocol. The mRNA expression levels of adipogenesis-related genes 
were evaluated by real-time PCR using gene-specific primers and 
SYBR Green Master PCR Kit (Takara, Shiga, Japan), according 
to the manufacturer’s instructions, with the real-time PCR iQTM5 
system (Bio-Rad Laboratories, Hercules, CA, USA). The primers 
were as follows: PPAR毭, 5’-TCACAAGAGGTGACCCAATG-3’ 
a n d  5 ’ - C C AT C C T T C A C A A G C AT G A A - 3 ’ ;  C / E B P
毩 ,  5 ’ - G T G T G C A C G T C TAT G C TA A A C C A - 3 ’ a n d 
5 ’ - G C C G T T A G T G A A G A G T C T C A G T T T G - 3 ’ ; 
F A B P 4 ,  5 ’ - C C A A T G A G C A A G T G G C A A G A -
3 ’ a n d  5 ’ - G AT G C C AG G C T C C AG G ATAG - 3 ’ ;  F A S , 
5 ’ - T G G T G G - G T T T G G T G A AT T G T C - 3 ’  a n d  5 ’ -
G C T T G T C C T G C T C TA A C T G G A A G T- 3 ’ ;  a n d 毬
-ac t in ,  5 ’ -TGTCCACCTTCCAGCAGATGT-3’ and  5’ - 
AGCTCAGTAACAGTCCGCCTAGA-3’. 
2.8. Protein extraction and Western blot analysis
  To prepare whole cell lysates, adipocytes were treated with various 
concentrations of MFBSE. After the treatment, cells were washed 
with ice-cold PBS and harvested in a lysis buffer (50 mM Tris-
HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 1% 
sodium deoxycholate, 0.1% SDS, 1 mM PMSF). The lysates were 
centrifuged at 12 000 rpm for 20 min, and the supernatants were 
collected. Total protein concentration was determined by Bio-Rad 
protein assay (Bradford, USA) using BSA as a standard. Aliquots (30 
毺g protein) were separated by 10% SDS-PAGE gel electrophoresis 
and transferred to polyvinylidene difluoride membranes (Amersham, 
Cleveland, OH, USA). The membranes were blocked with 5% (w/
v) non-fat dry milk in Tris-buffered saline containing 0.1% Tween 
20 (TBS-T) and were incubated with anti-mouse actin and FABP 
antibodies (Santa Cruz Biotechnology, Santa Cruz, CA, USA) or 
with anti-rabbit PPAR毭 and CEBP/毩 antibodies (Santa Cruz 
Biotechnology, Santa Cruz, CA, USA; 1:1 000 v/v) in 5% BSA 
in TBS-T. Following 16 h incubation at 4 曟, the membranes 
were washed with TBS-T and were incubated with horseradish 
peroxidase-conjugated anti-rabbit or anti-mouse IgG secondary 
antibody (Bio-Rad Laboratories, Hercules, CA, USA) in 5% non-
fat dry milk in TBS-T. After washing, the immunocomplexes were 
visualized by enhanced chemiluminescence reagents and detected by 
chemiluminometer (CLINX Science Instruments Co. Ltd., Shanghai, 
China). The expression levels of PPAR毭, C/EBP 毩, and FABP 
relative to those in the control group were determined.
2.9. High-performance Liquid Chromatography (HPLC) 
  The main constituents in MFBS were analyzed by HPLC analysis. 
Chromatographic analysis of MFBSE was performed on an Agilent 
1200 Series HPLC system (Agilent Technologies, Santa Clara, CA, 
USA). The column was a reversed-phase column, with dimensions 
of 4.6 mm伊250 mm. (Waters, Milford, MA, USA). The four 
isoflavones (daidzein, daidzin, genistein, and genistin) were analyzed 
as follows: the column temperature was maintained at 40 曟; the 
solvent was a mixture of (A) water: methanol: acetic acid (88:10:2, 
v/v/v) and (B) methanol: acetic acid (98:2, v/v) and was delivered 
at 1 mL/min in a gradient mode (10%-40% B in 21 min, 40% B for 
11 min, 40%-60% B in 3 min); and the isoflavones were detected 
by UV-Vis spectroscopy at 260 nm. Monacolin K was analyzed 
as follows: the column temperature was maintained at 40 曟; the 
mobile phase was (A) 0.2% phosphoric acid and (B) acetonitrile and 
was delivered at 1 ml/min in a gradient mode (35%-75% B in 20 
min, 75%-100% B in 1 min, 100% B for 14 min, 100%-35% B in 1 
min, 35% B for 14 min); and Monacolin K was detected by UV-Vis 
spectroscopy at 237 nm. 
2.10. Statistical analysis
  Data are expressed as means依SEM. The differences among 
treatment groups were analyzed by one-way ANOVA, followed 
by Duncan test, using Origin 7 Software (MicroCal Software, 
Northampton, MA, USA). Values of P<0.05 were considered to 
indicate statistical significance.
3. Results 
3.1. HPLC analysis of MFBS
  Monacolin K and four isoflavones (daidzein, daidzin, genistein, 
and genistin) from MFBS were analyzed by HPLC. To compare the 
relative contents of these constituents, monacolin K and isoflavones 
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were measured from the 75% ethanol extracts of M. pilousus-
fermented and unfermented black soybean. Although monacolin K 
was not detected in unfermented black soybean extracts, MFBSE 
significantly produced monacolin K (Figure 1A). Additionally, 
isoflavone aglycones, such as daidzein and genistein, were markedly 
induced by fermentation of MFBSE (Figure 1B). The ratios 
of isoflavone aglycones daidzein and genistein were increased 
approximately 2.9- and 4.4-fold, respectively, based on the peak 
areas. 
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Figure 1. HPLC analysis of MFBS. 
(A) Monacolin K content and (B) isoflavone content in M. pilosus-fermented 
black soybean and unfermented black soybean were analyzed by HPLC 
analysis. 
3.2. Effects of MFBSE on lipid accumulation and cell 
viability in 3T3-L1 adipocytes
  To determine the effect of MFBSE on lipid accumulation during 
differentiation, 3T3-L1 preadipocytes were induced to differentiate 
into adipocytes with MFBSE. Lipid accumulation was measured by 
Oil-Red O staining. MFBSE inhibited lipid accumulation in 3T3-
L1 adipocytes in a dose-dependent manner (Figure 2A). Treatment 
with 50 and 100 毺g/mL of MFBSE significantly reduced the 
lipid content by 25% (P<0.05) and 45% (P<0.001), respectively, 
compared with control. We performed the MTT assay to investigate 
the effect of MFBSE on cell viability of 3T3-L1 preadipocytes. 
MFBSE did not show any cytotoxicity after 48 h incubation at the 
tested concentrations (Figure 2B). These results demonstrated that 
MFBSE inhibits lipid accumulation. 
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Figure 2. Effects of MFBSE on lipid accumulation in 3T3-L1 adipocytes.
3T3-L1 adipocytes were treated with various doses (0, 25, 50, and 100 毺g/
mL) of MFBSE. (A) After 9 d, the cells were fixed and stained with Oil-Red 
O solution. Images of representative cells were captured with a microscope 
(200伊 magnification) and stained lipid content was quantified by measuring 
absorbance and expressed as the percentage of control. (B) Cell viability of 
3T3-L1 adipocytes was performed using MTT assay after 48 h treatment. 
Pre: preadipocyte; Con: differentiated adipocytes. **P<0.01 and *P<0.05 
compared with control. 
3.3. Effects of MFBSE on the expression levels of adipogenic 
transcription factor and related genes 
  To examine the possible mechanism by which adipogenesis is 
inhibited, we analyzed the effects of MFBSE on the expression 
**
**
*
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of adipogenic transcription factors and their target genes by using 
quantitative real-time PCR. PPAR毭 mRNA expression levels were 
decreased by 44% and 62% in 50 and 100 毺g/mL MFBSE groups, 
respectively, compared with the control group (P<0.05; Figure 
3A). C/EBP 毩 mRNA expression levels were decreased by 44% 
in the 100 毺g/mL MFBSE group compared with the control group 
(P<0.05; Figure 3B). FABP4 and FAS mRNA expression levels were 
reduced significantly in a dose-dependent manner in MFBSE-treated 
groups (FABP4: P<0.05 and P<0.01; FAS: P<0.05 and P<0.01; at 50 
and 100 毺g/mL, respectively; Figure 3C and D).
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Figure 3. Effects of MFBSE on the expression levels of genes related to 
adipogenesis in 3T3-L1 adipocytes. 
The mRNA expression levels of (A) PPAR毭, (B) C/EBP毩, (C) FABP4, 
and (D) FAS genes in 3T3-L1 adipocytes were determined using real-time 
PCR. The mRNA expression levels were normalized to 毬-actin mRNA level 
and expressed relative to those in the control group. Pre: preadipocyte; Con: 
differentiated adipocytes. **P<0.01 and *P<0.05 compared with the control.
3.4. Effects of MFBSE on the expression levels of 
adipogenesis-related proteins 
  We confirmed whether MFBSE affects the protein expression 
of adipogenesis-related proteins. PPAR毭 expression levels were 
reduced in a dose-dependent manner in MFBSE-treated groups 
and were reduced significantly in the 100 毺g/mL MFBSE group 
(Figure 4A and B). C/EBP毩 and FABP4 protein expression levels 
were reduced significantly in both the 50 and 100 毺g/mL MFBSE 
groups (Figure 4A, C and D). These results demonstrated that 
MFBSE inhibits lipid accumulation through the downregulation of 
adipogenic transcription factors and their targets. 
3.5. Effects of MFBSP on body weight gain, food intake, and 
organ weight
  The body weight gain, food intake, and organ weight are shown in 
Table 1. Body weight gain in the HFD control group was higher than 
the body weight gain in the NFD control group (P<0.005). Body 
weight gain in the MFBSP group was significantly lower than that in 
the HFD control group (P<0.05). Food intake was not significantly 
different among all groups. WAT and liver weights in the MFBSP 
group tented to be lower, but not significantly lower than in the 
HFD group. These results suggest that the MFBSP reduces the body 
weight gain without affecting food intake. 
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Figure 4. Effects of MFBSE on protein expression levels related to 
adipogenesis in 3T3-L1 adipocytes.
The protein expression levels were measured using (A) western blot analysis. 
(B) PPAR毭, (C) C/EBP毩, and (D) FABP4 protein levels were expressed 
as the fold increase relative to the control group after normalization to the 
毬-actin mRNA expression level. Pre: preadipocyte; Con: differentiated 
adipocytes. **P<0.01 and *P<0.05 compared with the control.
Table 1 
Effects of MFBSP on body weight, food intake and tissues weight in 
HFD-induced obese mice for 12 weeks.
Indexes NFD HFD HFD+MFBSP
Body weight (g)
Initial 24.32依0.26*** 30.78依1.17 29.78依0.64
Final 27.96依0.52*** 47.88依0.70 43.06依2.50*
Gain   3.64依0.20*** 17.10依1.14*** 13.28依2.30*
Food intake rate
(g/mouse/day)
  2.93依0.26   2.79依0.22   2.33依0.22
Tissue weight (g)
Liver   1.13依0.03   1.29依0.09   1.25依0.12
WAT   0.5依0.03***   2.86依0.13   2.64依0.30
Values are expressed as means依SEM (n = 5). ***P<0.005 and *P<0.05 
compared with the HFD control group.
3.6. Effects of MFBSP on adipogenesis-related genes 
expression
  We analyzed the effects of MFBSP on the mRNA levels of 
adipogenesis-related genes in WAT. In WAT, PPAR毭 mRNA 
expression levels tended to be reduced, but this reduction was not 
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significant (P=0.052; Figure 5A). aP2 and FAS mRNA expression 
levels were markedly reduced by 78% and 46%, respectively, in 
the MFBSP group compared with the HFD control group (P<0.05; 
Figure 5B and C). These results suggest that MFBS downregulates 
the mRNA expression of adipogenesis-related genes in WAT.
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Figure 5. Effects of MFBP on the expression levels of genes related to 
adipogenesis in the WAT of HFD-induced obese mice.
The relative mRNA levels of adipogenesis-related genes (A) PPAR毭, (B) 
FABP4, and (C) FAS in WAT of HFD-induced obese mice were measured by 
quantitative real-time PCR. The mRNA expression levels were normalized 
to 毬-actin mRNA level and expressed relative to those of the HFD control 
group. *P<0.05 compared with the HFD control group.
4. Discussion
  Obesity is a risk factor for metabolic syndromes including 
hyperlipidemia, type 2 diabetes, and cardiovascular disease[20,21]. 
Therefore, many studies have focused on prevention and treatment of 
obesity for achieving a healthy life. There are many drugs for obesity 
prevention, and treatments include reduction of nutrient absorption 
and regulation of lipid mobilization and utilization. Owing to the 
adverse side effects associated with many anti-obesity drugs, more 
recent trials have focused on screening for natural sources that have 
been reported to reduce body weight and that generally have minimal 
side effects[22]. This study is the first to investigate the in vitro and in 
vivo effects of M. pilosus-fermented black soybean (MFBS) on anti-
obesity and the mechanisms involved using 3T3-L1 adipocytes and 
HFD-induced obese mice. 
  Monascus sp. have been used as traditional edible fungi, natural 
food colorant and preservative, and traditional medicine for 
improving blood circulation. Monacolin K, a secondary metabolite 
of Monascus sp., is a known inhibitor of HMG-CoA reductase 
in cholesterol metabolism[8,9]. Additionally, black soybean and 
its products fermented with various filamentous fungi have been 
used as foods for promotion of health[19]. In this study, we found 
that the content of monacolin K, daidzein, and genistein was 
higher in MFBS than in unfermented black soybean. This finding 
suggests that the endogenous glucoside form of isoflavone in black 
soybean is converted into aglycones by M. pilosus-fermentation, 
in agreement with the increase in content of isoflavone aglycones 
and decrease of glucosides observed upon soaking soybeans in 
water and processing[12]. It has been reported that aglycones have 
the ability to lower fat accumulation and plasma lipids levels in 
vitro and in vivo[9,13,14]. We found that MFBS extracts showed less 
lipid accumulation in adipocytes than M. pilosus extracts and black 
soybean extracts (data not shown). These results suggest that MFBS 
containing monacolin K, daidzein, and genistein might regulate lipid 
accumulation more efficiently than non-fermented black soybean, 
and the interaction between these bioactive components could 
play important roles in the regulation of obesity. Thus, MFBS was 
employed in additional experiments. 
  The results from lipid staining by Oil-Red O in adipocytes show 
that MFBSE suppresses adipogenesis without cell cytotoxicity. In 
addition, our in vivo study demonstrated that MFBSP significantly 
reduced the body weight gain of mice, although it showed a 
tendency to lower WAT weight. These results suggest that MFBS 
exerts anti-obesity effects in adipocytes and in HFD-induced obese 
mice. Previous studies have also confirmed that Monascus-fermented 
products have anti-obesity and hypolipidemia effects in adipocytes 
and in HFD-induced obese animals[11,23,24]. 
  Obesity is characterized by increased fat accumulation, which is 
associated with an increase in the cell number and/or cell size of 
adipocytes differentiated from preadipocytes[3,4,6,7]. Adipogenesis 
is the process by which undifferentiated preadipocytes are 
converted to differentiated adipocytes, which is closely associated 
with the etiologies of obesity[25]. The entire adipogenic process is 
accompanied by sequential expression and activation of transcription 
factors, such as C/EBP毩, PPAR毭, and ADD/SREBP-1[26,27]. 
Among them, PPAR毭, a ligand-activated transcription factor that is 
expressed during the early to middle stages of adipogenesis, regulates 
adipogenesis through modulating the expression of its target genes, 
including fatty aP2 and FAS, which are responsible for TG synthesis 
and accumulation during adipocyte differentiation[28,29]. C/EBP
毩 is expressed in the late stage of adipogenesis and stimulates the 
differentiation of preadipcoytes in cooperation with PPAR毭. In this 
study, MFBSE reduced the mRNA and protein expression levels of 
adipogenesis-related genes such as PPAR毭, C/EBP毩, FABP4, and 
FAS. Furthermore, mRNA expression levels of these genes were 
reduced in WAT of HFD-induced obese mice, although the WAT 
weights tended to be reduced in MFBSP-treated group. These results 
suggest that reduction of expression of adipogenesis-related genes by 
MFBSE and MFBSP might explain the inhibition of differentiation 
and lipid accumulation of adipocytes and WAT of HFD-induced 
obese mice.
  In conclusion, our results show that MFBS prevents the 
development of obesity in adipocytes and in HFD-induced obese 
mice by regulating the mRNA expression of genes associated with 
adipogenesis. These results suggest that MFBS can potentially be 
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used as an anti-obesity therapy. 
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